{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:42:18Z","timestamp":1790664138476,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T00:00:00Z","timestamp":1504828800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006285","name":"Magnus Bergvalls Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006285","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stockholm Country Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s12020-017-1400-8","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T12:25:23Z","timestamp":1505132723000},"page":"267-275","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3016-6760","authenticated-orcid":false,"given":"Jekaterina","family":"Patrova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Kjellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Wahrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"issue":"4","key":"1400_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/EJE-15-0272","volume":"173","author":"G Dalmazi Di","year":"2015","unstructured":"G. Di Dalmazi, R. Pasquali, F. Beuschlein, M. Reincke, Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur. J. Endocrinol. 173(4), 61\u201371 (2015)","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1400_CR2","first-page":"1","volume":"19","author":"N. I. H. Consensus and S. Statements","year":"2002","unstructured":"N. I. H. Consensus and S. Statements, NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (\u2018incidentaloma\u2019). NIH Consens State Sci. Statements 19(2), 1\u201325 (2002)","journal-title":"NIH Consens State Sci. Statements"},{"issue":"2","key":"1400_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"M Fassnacht","year":"2016","unstructured":"M. Fassnacht, W. Arlt, I. Bancos, I. Dralle, Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors. Eur. J. Endocrinol. 175(2), 1\u201334 (2016)","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"1400_CR4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2265.1998.00357.x","volume":"48","author":"M Terzolo","year":"1998","unstructured":"M. Terzolo, G. Osella, A. Al\u00ec, G. Borretta, F. Cesario, P. Paccotti, Subclinical Cushing\u2019s syndrome in adrenal incidentaloma. Clin. Endocrinol. 48(1), 89\u201397 (1998)","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"1400_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S1.1","volume":"15","author":"M Zeiger","year":"2009","unstructured":"M. Zeiger, G.B. Thompson, Q.-Y. Duh, A.H. Hamrahian, P. Angelos, D. Elaraj, E. Fishman, The American association of clinical endocrinologists and American association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas. Endocr. Pract. 15(1), 1\u201320 (2009)","journal-title":"Endocr. Pract."},{"key":"1400_CR6","doi-asserted-by":"crossref","unstructured":"M. Debono, J. Newell-Price, Subclinical hypercortisolism in adrenal incidentaloma. Curr. Opin. Endocrinol. Diabetes. Obes. 22(3), 185\u2013192 (2015)","DOI":"10.1097\/MED.0000000000000151"},{"issue":"12","key":"1400_CR7","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","volume":"99","author":"M Debono","year":"2014","unstructured":"M. Debono, M. Bradburn, M. Bull, B. Harrison, R.J. Ross, J. Newell-Price, Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J. Clin. Endocrinol. Metab. 99(12), 4462\u20134470 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"1400_CR8","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, L. Frisen, A.L. Hirschberg, C. Norrby, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study. J. Clin. Endocrinol. Metab. 100(9), 3520\u20133528 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"1400_CR9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4158\/EP15618.OR","volume":"21","author":"J Patrova","year":"2015","unstructured":"J. Patrova, I. Jarocka, H. Wahrenberg, H. Falhammar, Clinical outcomes in adrenal incidentaloma: experience from one center. Endocr. Pract. 21(8), 870\u2013877 (2015)","journal-title":"Endocr. Pract."},{"issue":"2","key":"1400_CR10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0022-5347(05)67888-3","volume":"163","author":"L Barzon","year":"2000","unstructured":"L. Barzon, M. Boscaro, Diagnosis and management of adrenal incidentalomas. J. Urol. 163(2), 398\u2013407 (2000)","journal-title":"J. Urol."},{"issue":"3","key":"1400_CR11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/eje.1.02110","volume":"154","author":"B B\u00fclow","year":"2006","unstructured":"B. B\u00fclow, S. Jansson, C. Juhlin, L. Steen, M. Thor\u00e9n, H. Wahrenberg, S. Valdemarsson, B. W\u00e4ngberg, B. Ahr\u00e9n, Adrenal incidentaloma-Follow up results from a Swedish prospective study. Eur. J. Endocrinol. 154(3), 419\u2013423 (2006)","journal-title":"Eur. J. Endocrinol."},{"key":"1400_CR12","doi-asserted-by":"crossref","unstructured":"H. Yeomans, J. Calissendorff, C. Volpe, H. Falhammar, B. Mannheimer, Limited value of long-term biochemical follow-up in patients with adrenal incidentalomas-a retrospective cohort study. BMC Endocr. Disord. 15(6), 1\u20136 (2015)","DOI":"10.1186\/s12902-015-0001-x"},{"issue":"2","key":"1400_CR13","first-page":"520","volume":"84","author":"L Barzon","year":"1999","unstructured":"L. Barzon, C. Scaroni, N. Sonino, F. Fallo, Risk factors and long-term follow-up of adrenal incidentalomas. J. Clin. Endocrinol. Metab. 84(2), 520\u2013526 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1400_CR14","unstructured":"L. Barzon, F. Fallo, N. Sonino, M. Boscaro, Development of overt Cushing\u2019s syndrome in patients with adrenal incidentaloma. Eur. J. Endocrinol. 146, 61\u201366 (2002)"},{"issue":"4","key":"1400_CR15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/eje.0.1470489","volume":"147","author":"R Lib\u00e8","year":"2002","unstructured":"R. Lib\u00e8, C. Dall\u2019Asta, L. Barbetta, A. Baccarelli, P. Beck-Peccoz, B. Ambrosi, Long-term follow-up study of patients with adrenal incidentalomas. Eur. J. Endocrinol. 147(4), 489\u2013494 (2002)","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"1400_CR16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"G Dalmazi Di","year":"2014","unstructured":"G. Di Dalmazi, V. Vicennati, S. Garelli, E. Casadio, E. Rinaldi, E. Giampalma, C. Mosconi, R. Golfieri, A. Paccapelo, U. Pagotto, R. Pasquali, Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2(5), 396\u2013405 (2014)","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"8","key":"1400_CR17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.psyneuen.2003.11.003","volume":"29","author":"HC Abercrombie","year":"2004","unstructured":"H.C. Abercrombie, J. Giese-Davis, S. Sephton, E.S. Epel, J.M. Turner-Cobb, M. Spiegel, Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 29(8), 1082\u20131092 (2004)","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"1400_CR18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bbi.2009.07.007","volume":"23","author":"SE Sephton","year":"2009","unstructured":"S.E. Sephton, F.S. Dhabhar, A.S. Keuroghlian, J. Giese-Davis, B.S. McEwen, A.C. Ionan, D. Spiegel, Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain Behav. Immun. 23(8), 1148\u20131155 (2009)","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"1400_CR19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/jnci\/94.9.690","volume":"94","author":"E Filipski","year":"2002","unstructured":"E. Filipski, V.M. King, X. Li, T.G. Granda, M.-C. Mormont, X. Liu, B. Claustrat, M.H. Hastings, F. L\u00e9vi, Host circadian clock as a control point in tumor progression. J. Natl Cancer Inst. 94(9), 690\u2013697 (2002)","journal-title":"J. Natl Cancer Inst."},{"key":"1400_CR20","doi-asserted-by":"crossref","unstructured":"R.M. Sapolsky, T.M. Donnelly, Vulnerability to Stress-Induced Tumor Growth Increases with Age in Rats: role of glucocorticoids. Endocrinology 117(2), 662\u2013666 (1985)","DOI":"10.1210\/endo-117-2-662"},{"issue":"4","key":"1400_CR21","first-page":"867","volume":"60","author":"TJ Moran","year":"2000","unstructured":"T.J. Moran, S. Gray, C.A. Mikosz, S.D. Conzen, The glucocorticoid receptor mediates a survival signal in human mammary epithelial cells. Cancer Res. 60(4), 867\u2013872 (2000)","journal-title":"Cancer Res."},{"issue":"7","key":"1400_CR22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tem.2005.07.002","volume":"16","author":"TM Rae","year":"2005","unstructured":"T.M. Rae, S.H. Hillier, Steroid signalling in the ovarian surface epithelium. Trends Endocrinol. Metab. 16(7), 327\u2013333 (2005)","journal-title":"Trends Endocrinol. Metab."},{"issue":"4","key":"1400_CR23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-11-1039","volume":"166","author":"G Dalmazi Di","year":"2012","unstructured":"G. Di Dalmazi, V. Vicennati, E. Rinaldi, A.M. Morselli-Labate, E. Giampalma, C. Mosconi, U. Pagotto, R. Pasquali, Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur. J. Endocrinol. 166(4), 669\u2013677 (2012)","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"1400_CR24","first-page":"1440","volume":"85","author":"R Rossi","year":"2000","unstructured":"R. Rossi, L. Tauchmanova, A. Luciano, M.D.I. Martino, C. Battista, O. Molecolare, Subclinical cushing\u2019s syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J. Clin. Endocrinol. Metabol. 85(4), 1440\u20131448 (2000)","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"1400_CR25","doi-asserted-by":"crossref","unstructured":"G. Di Dalmazi, Update on the risks of benign adrenocortical incidentalomas. Curr. Opin. Endocrinol. Diabetes Obes. 193\u2013199, (2017)","DOI":"10.1097\/MED.0000000000000341"},{"key":"1400_CR26","doi-asserted-by":"crossref","unstructured":"D. Lopez, M.A. Luque-Fernandez, A. Steele, G.K. Adler, A. Turchin, A. Vaidya, \u2018Nonfunctional\u2019 adrenal tumors and the risk for incident diabetes and cardiovascular outcomes. Ann. Intern. Med. 165(8), 533\u2013542 (2016)","DOI":"10.7326\/M16-0547"},{"issue":"1","key":"1400_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12020-012-9622-2","volume":"42","author":"H Olsen","year":"2012","unstructured":"H. Olsen, E. Nordenstr\u00f6m, A. Bergenfelz, U. Nyman, S. Valdemarsson, E. Palmqvist, Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden. Endocrine 42(1), 164\u2013172 (2012)","journal-title":"Endocrine"},{"issue":"6","key":"1400_CR28","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","volume":"54","author":"AS Mihailidou","year":"2009","unstructured":"A.S. Mihailidou, T.Y.L. Le, M. Mardini, Y.W. Funder, Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 54(6), 1306\u20131312 (2009)","journal-title":"Hypertension"},{"issue":"1","key":"1400_CR29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000318566","volume":"92","author":"M Leo De","year":"2010","unstructured":"M. De Leo, R. Pivonello, R.S. Auriemma, A. Cozzolino, P. Vitale, C. Simeoli, M.C. De Martino, G. Lombardi, A. Colao, Cardiovascular disease in Cushing\u2019s syndrome: heart versus vasculature. Neuroendocrinology 92(1), 50\u201354 (2010)","journal-title":"Neuroendocrinology"},{"issue":"3","key":"1400_CR30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","volume":"249","author":"A Toniato","year":"2009","unstructured":"A. Toniato, I. Merante-Boschin, G. Opocher, M.R. Pelizzo, F. Schiavi, E. Ballotta, Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann. Surg. 249(3), 388\u2013391 (2009)","journal-title":"Ann. Surg."},{"issue":"8","key":"1400_CR31","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/jc.2013-4064","volume":"99","author":"II Androulakis","year":"2014","unstructured":"I.I. Androulakis, G.A. Kaltsas, G.E. Kollias, A.C. Markou, A.K. Gouli, D.A. Thomas, K.I. Alexandraki, C.M. Papamichael, D.J. Hadjidakis, G.P. Piaditis, Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. J. Clin. Endocrinol. Metab. 99(8), 2754\u20132762 (2014)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1400-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1400-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1400-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T05:34:04Z","timestamp":1570080844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1400-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1400"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1400-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,8]]}}}